Article 27 Dec 2022 Board Reaffirms That Assignor Estoppel Does Not Bar Assignor From Filing IPR Petition United States IP
Article 22 Aug 2022 Honesty Is The Best Policy: USPTO Clarifies Duties Of Disclosure And Reasonable Inquiry For Pharmaceutical Patents United States IP
Article 14 Apr 2022 Considerations For Protecting Trade Secrets In FDA Correspondence United States IP
Article 12 Sep 2019 35 U.S.C. § 314(d) Prevents Appeal Of PTAB's Decision To Deny Institution Upon Reconsideration United States IP
Article 01 Apr 2019 FDA Procedures For Handling Requests For Nonproprietary Name Suffix Review For Biological Products Newly Licensed Under Section 351 Of The PHS Act United States Healthcare
Article 29 Jan 2019 FDA Draft Guidance On Common Issues In Drug Development For Rare Diseases United States Healthcare
Article 08 Jan 2019 CAFC Holds ITC Must Grant Relief Against Defaulting Respondents Under 19 U.S.C. § 1337(G)(1) In Laerdal Medical Corp. v. ITC United States Healthcare
Article 03 Jan 2019 Statute Requires ITC Grant Relief Against Defaulting Respondents, Subject To Public Interest United States IP
Article 28 Dec 2018 First Revision To Questions And Answers On Biosimilar Development United States Healthcare